Patrizia Alessi1, Daria Leali1, Maura Camozzi1, AnnaRita Cantelmo2, Adriana Albini2, Marco Presta1
European Cytokine Network, Vol.20, No.4, pp. 225-234, 2009, DOI:10.1684/ecn.2009.0175
Abstract Angiogenesis, the formation of new blood vessels from the endothelium of the existing vasculature,
plays a pivotal role in tumor growth, progression and metastasis. Over the last 30 years, numerous pro- and
antiangiogenic molecules, their ligands, and intracellular signaling pathways have been identified, and signifi-cant
efforts have been undertaken to develop antiangiogenic strategies for cancer therapy. Agents that selec-tively
target vascular endothelial growth factor (VEGF) and its receptors have shown promising activity in clin-ical
trials and have been approved for use in selected cancer indications. However, patients may ultimately
develop resistance to these drugs. One… More >